Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 11
346
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

In vitro cytotoxicity evaluation of thiourea derivatives bearing Salix sp. constituent against HK-1 cell lines

, , , , , , & show all
Pages 1505-1514 | Received 07 May 2018, Accepted 24 Aug 2018, Published online: 03 Dec 2018

References

  • Abd Halim AN, Ngaini Z. 2017. Synthesis and characterization of halogenated bis(acylthiourea) derivatives and their antibacterial activities. Phosphorus, Sulfur, Silicon Relat Elem. 192(9):1012–1017.
  • Adinarayana KPS, Reddy PA, Babu PA. 2012. Structural studies on docking selective COX-2 inhibitors. J Bioinform Res. 1:21–26.
  • Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. 1998. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 16(4):1310–1317.
  • Ansari MM, Deshmukh SP, Khan R, Musaddiq M. 2014. Synthesis antimicrobial and anticancer evaluation of 1-Aryl-5-(o-methoxyphenyl)-2-S-benzyl isothiobiurets. Int J Med Chem. 2014:1–6.
  • Bielenica A, Stefańska J, Stępień K, Napiórkowska A, Augustynowicz-Kopeć E, Sanna G, Madeddu S, Boi S, Giliberti G, Wrzosek M, Struga M. 2015. Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety. Eur J Med Chem. 101:111–125.
  • Chavan BB, Chitte PD, Choudhary NP, Albhar KG, Hukkeri VI. 2012. Synthesis and biological evaluation of novel benzimidazole derivative with aspirin as potent antimicrobial & antifungal agents. Int J Sci Res Rev. 1:22–30.
  • Chen J, Ran Y, Hong C, Chen Z, You Y. 2010. Anticancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoprotein. Cytotechnology. 62(5):431–438.
  • Desborough MJR, Keeling DM. 2017. The aspirin story – from willow to wonder drug. Br J Haematol. 177(5):674–683.
  • El-Gohary NS, Shaaban MI. 2013. Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of fused [1,3,4]thiadiazoles. Eur J Med Chem. 63:185–195.
  • Fathalla WM, Čajan M, Marek J, Pazdera P. 2001. One-pot quinazolin-4-ylidenethiourea synthesis via N-(2-cyanophenyl)benzimidoyl isothiocyanate. Molecules. 6(7):574–587.
  • Feng ZQ, Yang XL, Ye YF, Hao LY. 2014. The effect of electron-withdrawing group functionalization on antibacterial and catalytic activity of palladium (II) complexes. Bull Korean Chem Soc. 35(4):1121–1127.
  • Huang DP, Ho JHC, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH, Lau WH. 1980. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer. 26(2):127–132.
  • Huang L, Mackenzie GG, Ouyang N, Sun Y, Xie G, Johnson F, Komninou D, Rigas B. 2011. The Novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats. Br J Pharmacol. 162(7):1521–1533.
  • Huang L, Wong CC, Mackenzie GG, Sun Y, Cheng KW, Vrankova K, Alston N, Ouyang N, Rigas B. 2014. Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress. BMC Cancer. 14(1):1–14.
  • Jain AK, Vaidya A, Ravichandran V, Kashaw SK, Agrawal RM. 2012. Recent developments and biological activities of thiazolidinone derivatives: a review. Bioorg Med Chem. 20(11):3378–3395.
  • Katritzky AR, Ledoux S, Witek RM, Nair SK. 2004. 1-(Alkyl/arylthiocarbamoyl)benzotriazoles as stable isothiocyanate equivalents: synthesis of di- and trisubstituted thioureas. J Org Chem. 69(9):2976–2982.
  • Kaymakcioglu BK, Celen AO, Tabanca N, Ali A, Khan SI, Khan IA, Wedge DE. 2013. Synthesis and biological activity of substituted urea and thiourea derivatives containing 1,2,4-triazole moieties. Molecules. 18(3):3562–3576.
  • Khan MF, Rashid R, Rashid MA. 2015. Computational study of geometry, molecular properties and docking study of aspirin. World J Pharm Res. 4:2702–2714.
  • Mahdi JG. 2010. Medicinal potential of willow: a chemical perspective of aspirin discovery. J Saudi Chem Soc. 14(3):317–322.
  • Mahdi JG, Mahdi AJ, Mahdi AJ, Bowen ID. 2006. The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Prolif. 39(2):147–155.
  • Modi NR, Shah RJ, Patel MJ, Suthar M, Chauhan BF, Patel LJ. 2011. Design, synthesis, and QSAR study of novel 2-(2,3-dioxo-2,3-dihydro-1H-indol-1-yl)-N-phenyl acetamide derivatives as cytotoxic agents. Med Chem Res. 20(5):615–625.
  • Ngaini Z, Arif MAM, Hussain H, Er SM, Tang D, Kamaluddin DHA. 2012. Synthesis and antibacterial activity of acetoxybenzoyl thioureas with aryl and amino acid side chains. Phosphorus, Sulfur, Silicon Relat Elem. 187(1):1–7.
  • Ngaini Z, Mortadza NA. 2018. Synthesis of halogenated azo-aspirin analogues from natural product derivatives as the potential antibacterial agents. Nat Prod Res. 1. DOI: 10.1080/14786419.2018.1486310
  • Nguyen TT, Tran DP, Huy PDQ, Hoang Z, Carloni P, Pham PV, Nguyen C, Li MS. 2016. Ligand binding to anti-cancer target CD44 investigated by molecular simulations. J Mol Model. 22:165–179.
  • Nordin NA, Chai TW, Tan BL, Choi CL, Halim AN, Hussain H, Ngaini N. 2017. Novel synthetic monothiourea aspirin derivatives bearing alkylated amines as potential antimicrobial agents. J Chem. 2017:1–7.
  • Orlando BJ, Malkowski MG. 2016. Substrate-selective Inhibition of cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone. J Biol Chem. 291(29):15069–15081.
  • Prabhashankar J, Govindappa VK, Renuka N, Akshatha KN, Mahadevamurthy S, Kariyappa AK. 2012. Evaluation and Studies on the Structural Impact of 3-aryl-5-(4-methoxyphenyl)-4,5-dihydroisoxazole-4-carbonitriles on their Biological Activities. Pharm Lett. 4:1685–1691.
  • Rauf MK, Imtiaz-Ud-Din BA, Gielen M, Ebihara M, de Vos D, Ahmed S. 2009. Synthesis, structural characterization and in vitro cytotoxicity and anti-bacterial activity of some copper (I) complexes with N,N’-disubstituted thioureas. J Inorg Biochem. 103:1135–1144.
  • Saeed A, Shaheen U, Hameed A, Naqvi SZH. 2009. Synthesis, characterization and antimicrobial studies of some new 1-(fluorobenzoyl)-3-(fluorophenyl) thioureas. J Fluorine Chem. 130(11):1028–1034.
  • Saeed S, Rashid N, Ali M, Hussain R, Jones P. 2010. Synthesis, spectroscopic characterization, crystal structure and pharmacological properties of some novel thiophene-thiourea core derivatives. Eur J Chem. 1(3):221–227.
  • Shirasaka T, Murakami K, Ford H, Kelley JA, Yoshioka H, Kojima E, Aoki S, Broder S, Mitsuy H. 1990. Lipophilic Halogenated Congeners of 2’,3’-dideoxypurine Nucleosides Active Against Human Immunodeficiency Virus In Vitro. Proc Natl Acad Sci USA. 87(23):9426–9430.
  • Turnbull CM, Marcarino P, Sheldrake TA, Lazzarato L, Cena C, Fruttero R, Gasco A, Fox S, Megson IL, Rossi AG. 2008. A novel hybrid aspirin-NO-releasing compound inhibits TNF alpha release from LPS-activated human monocytes and macrophages. J Inflamm. 5(1):10–12.
  • Vane JR, Botting RM. 2003. The mechanism of action of aspirin. Thromb Res. 110(5-6):255–258.
  • Vaz RJ, Klabunde T. 2008. Antitargets: prediction and prevention of drug side effects. Germany: Wiley-VCH.
  • Wan Zullkiplee WSH, Abd Halim AN, Ngaini Z, Mohd Ariff MA, Hussain H. 2014. Bis-thiourea bearing aryl and amino acids side chains and their antibacterial activities. Phosphorus, Sulfur Silicon Relat. Elem. 189(6):832–838.
  • Yahyazadeh A, Ghasemi Z. 2013. Synthesis of unsymmetrical thiourea derivatives. Eur Chem Bull. 2:573–575.
  • Zhao W, Bai JK, Li HM, Chen T, Tang YJ. 2015. Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity. Sci Rep. 5:10172–10183.
  • Zhou Y, Sun Z, Froelich JM, Hermann T, Wall D. 2006. Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines. Bioorg Med Chem Lett. 16(20):5451–5456.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.